| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |